Celltrion Bags FDA Approval For High-Concentration Humira Rival
Yuflyma, Ninth US Adalimumab Biosimilar, Will Be Marketed Directly By Korean Firm
• By David Wallace
Celltrion has obtained approval for a 100mg/ml adalimumab biosimilar • Source: Shutterstock 
